Therapeutic for treating Clostridium difficile infection
AssigneeLondon School of Hygiene and Tropical Medicine
InventorsLisa Dawson, Brendan Wren
Life of this patent
Estimating the term…
Loading patent…
AssigneeLondon School of Hygiene and Tropical Medicine
InventorsLisa Dawson, Brendan Wren
Estimating the term…
The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a combination therapeutic comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a method of treating a mammal suspected of being infected with, or infected with, C. difficile comprising the use of at least deoxyribonuclease; a method of cleaning or sterilizing a material or product comprising the use of at least deoxyribonuclease; and a cleaning or sterilizing product impregnated with or containing at least deoxyribonuclease.
A method of treating Clostridium difficile biofilm formation in a mammal, comprising administering to said mammal an effective amount of a DNase I deoxyribonuclease or a functional fragment thereof, thereby degrading the Clostridium difficile biofilm.
Dependencies are inferred from the claim text.